tiprankstipranks
Prometheus Biosciences (RXDX)
NASDAQ:RXDX
US Market

Prometheus Biosciences (RXDX) Financial Statements

0 Followers

Prometheus Biosciences Financial Overview

Prometheus Biosciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Prometheus Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 1.10M$ 653.00K$ 968.00K$ 1.27M$ 3.92M
Gross Profit$ 1.10M$ 653.00K---
EBIT$ -48.51M$ -41.31M$ -37.27M$ -33.65M$ -32.07M
EBITDA$ 0.00$ -42.74M$ -37.11M$ -33.49M$ -31.98M
Net Income Common Stockholders$ -40.68M$ -38.74M$ -37.27M$ -33.65M$ -32.07M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 713.67M$ 695.75M$ 260.25M$ 211.78M$ 227.03M
Total Assets$ 754.71M$ 740.77M$ 298.62M$ 237.59M$ 253.58M
Total Debt$ 29.46M$ 29.54M$ 29.21M$ 14.76M$ 14.62M
Net Debt$ -684.21M$ -666.21M$ -231.03M$ -197.02M$ -212.41M
Total Liabilities$ 60.80M$ 64.81M$ 66.08M$ 45.76M$ 46.86M
Stockholders Equity$ 697.59M$ 675.97M$ 232.53M$ 191.83M$ 206.72M
Cash Flow-
Free Cash Flow-$ -41.49M$ -24.39M$ -29.73M$ -30.34M
Operating Cash Flow-$ -41.12M$ -23.90M$ -28.85M$ -29.39M
Investing Cash Flow-$ -220.20M$ -65.76M$ -116.86M$ -955.00K
Financing Cash Flow-$ 475.33M$ 72.11M$ 14.63M$ 123.00K
Currency in USD

Prometheus Biosciences Earnings and Revenue History

Prometheus Biosciences Debt to Assets

Prometheus Biosciences Cash Flow

Prometheus Biosciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis